Methodology Data is from the Febraury 2025 Dentsu report titled "GLP-1s: Impact on Consumer Categories" conducted by Toluna
In contrast to these results, a study using nationwide registry data from Sweden, Denmark, and Norwayinvolving 121,254 new GLP-1 RA users and 185,027 new SGLT-2 inhibitor users documented 557 intestinal obstruction events, with no significant correlation between GLP-1 RA use and increased intestinal obstruction risk, thereby refuting earlier safety concerns [12]
All cases were asymptomatic and reported duration was ranged from one week to twelve months
Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux
Learning about common peptide mistakes helps you avoid these errors from the start
This includes altering the bodys ability to produce histamine